Frandsen A, Schousboe A
Department of Biological Sciences, Royal Danish School of Pharmacy, Copenhagen.
J Neurochem. 1993 Apr;60(4):1202-11. doi: 10.1111/j.1471-4159.1993.tb03278.x.
A large body of evidence suggests that disturbances of Ca2+ homeostasis may be a causative factor in the neurotoxicity induced by excitatory amino acids (EAAs). The route or routes by which an increase in intracellular calcium concentration ([Ca2+]i) is mediated in vivo are presently not clarified. This may partly reflect the complexity of intact nervous tissue in combination with the relative unspecific action of the available "calcium antagonists," e.g., blockers of voltage-sensitive calcium channels. By using primary cultures of cortical neurons as a model system, it has been found that all EAAs stimulate increases in [Ca2+]i but via different mechanisms. By using the drug dantrolene, it has been shown that 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionate (AMPA) apparently exclusively stimulates Ca2+ influx through agonist-operated calcium channels and voltage-operated calcium channels. Increased [Ca2+]i due to exposure to kainate (KA) is for the major part caused by influx, as in the case of AMPA, but a small part of the increase in [Ca2+]i may be attributed to a release of Ca2+ from intracellular stores. Quisqualate (QA) stimulates Ca2+ release from an intracellular store that is independent of Ca2+ influx; presumably this store is activated by inositol phosphates. The increase in [Ca2+]i due to exposure to glutamate or N-methyl-D-aspartate (NMDA) may be compartmentalized into three components, one of which is related to influx and the other two to Ca2+ release from internal stores. Only one of the latter stores is dependent on Ca2+ influx with regard to release of Ca2+, whereas the other is activated by some other second messengers or, alternatively, directly coupled to the receptor. In muscles dantrolene is known to inhibit Ca2+ release from the sarcoplasmic reticulum, and also in neurons dantrolene inhibits an equivalent release from one or more hitherto unidentified internal Ca2+ pool(s). By using this drug it has been possible to show to what extent these Ca2+ stores are involved in the toxicity observed subsequent to exposure to the EAAs. It turned out that dantrolene, even under conditions allowing Ca2+ influx, inhibited toxicity induced by QA, NMDA, and glutamate, whereas that induced by AMPA or KA was unaffected. In combination with the findings that dantrolene inhibited release from the intracellular stores activated by QA, NMDA, and glutamate, it may be concluded that Ca2+ influx per se is not the primary event causing toxicity following exposure to these EAAs in these neurons. However, it may certainly be involved in the cases of toxicity induced by AMPA and KA.(ABSTRACT TRUNCATED AT 400 WORDS)
大量证据表明,Ca2+ 稳态紊乱可能是兴奋性氨基酸(EAA)诱导神经毒性的一个致病因素。目前尚不清楚体内细胞内钙浓度([Ca2+]i)升高是通过何种途径介导的。这可能部分反映了完整神经组织的复杂性,以及现有“钙拮抗剂”(如电压敏感性钙通道阻滞剂)相对非特异性的作用。通过使用皮层神经元原代培养作为模型系统,发现所有 EAA 都能刺激 [Ca2+]i 升高,但机制不同。使用药物丹曲林已表明,2-氨基-3-(3-羟基-5-甲基异恶唑-4-基)丙酸(AMPA)显然仅通过激动剂操纵的钙通道和电压操纵的钙通道刺激 Ca2+ 内流。与 AMPA 情况一样,暴露于 kainate(KA)导致的 [Ca2+]i 升高主要是由内流引起的,但 [Ca2+]i 升高的一小部分可能归因于细胞内钙库释放 Ca2+。quisqualate(QA)刺激从与 Ca2+ 内流无关的细胞内钙库释放 Ca2+;据推测,这个钙库是由肌醇磷酸激活的。暴露于谷氨酸或 N-甲基-D-天冬氨酸(NMDA)导致的 [Ca2+]i 升高可分为三个部分,其中一个与内流有关,另外两个与从内部钙库释放 Ca2+ 有关。就 Ca2+ 释放而言,后两个钙库中只有一个依赖于 Ca2+ 内流,而另一个则由其他一些第二信使激活,或者直接与受体偶联。在肌肉中,已知丹曲林可抑制肌浆网释放 Ca2+,在神经元中,丹曲林也抑制从一个或多个迄今未确定的内部 Ca2+ 池的等效释放。通过使用这种药物,已能够表明这些 Ca2+ 池在暴露于 EAA 后观察到的毒性中所起的作用程度。结果表明,即使在允许 Ca2+ 内流的条件下,丹曲林也能抑制 QA、NMDA 和谷氨酸诱导的毒性,而 AMPA 或 KA 诱导的毒性则不受影响。结合丹曲林抑制 QA、NMDA 和谷氨酸激活的细胞内钙库释放的发现,可以得出结论,Ca2+ 内流本身不是这些神经元暴露于这些 EAA 后导致毒性的主要事件。然而,在 AMPA 和 KA 诱导的毒性情况下,它肯定可能参与其中。(摘要截取自 400 字)